By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1500 First Avenue North
Suite L140
Birmingham  Alabama  35203  U.S.A.
Phone: 205-307-6535 Fax: n/a



Company News
BIO2016: DiscoveryBioMed Is Announcing Its Newly Redesigned Website, Its New Online Store, And Other Advances At BIO 2016 In San Francisco 6/6/2016 8:24:42 AM
DiscoveryBioMed Is Developing A Novel “Dual Action” Small Molecule Monotherapy For All Cystic Fibrosis (CF) Patients 4/14/2015 8:56:30 AM
DiscoveryBioMed Is Awarded A New Phase II SBIR Grant Award To Develop New Medicines To Fight The Diabetes And Obesity Epidemic In The U.S. And Globally 4/8/2015 10:52:57 AM
DiscoveryBioMed Awarded Dual SBIRAwards For Polycystic Kidney Disease (PKD) Drug Discovery, Validation, Optimization And Development 10/7/2014 10:16:30 AM
DiscoveryBioMed Garners Funding from the National Institutes of Health (NIH) to Support a Metabolic Diseases Drug Discovery Program 7/2/2012 9:58:38 AM
DiscoveryBioMed Has Graduated from the Business Incubator Program at Innovation Depot 9/14/2011 10:37:51 AM
DiscoveryBioMed Receives $1.35 Million SBIR Award from the National Institutes of Health (NIH) to Continue Its Cystic Fibrosis Drug Discovery Program 9/14/2011 10:36:57 AM
DiscoveryBioMed Committed to Polycystic Kidney Disease Research Reagent Development and PKD-Specific Drug Discovery as a Core Disease with Unmet Need 11/16/2010 10:03:15 AM
DiscoveryBioMed Awarded Phase 1 SBIR Catalyst Grant under The Recovery Act by the National Institutes of Health (NIH) to Discover Anti-Inflammatory Drugs 4/20/2010 1:43:14 PM
DiscoveryBioMed Awarded $300,000 National Institutes of Health (NIH) Grant for Cystic Fibrosis Drug Research and Development 10/28/2009 9:26:25 AM